Dominik Kylies
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dominik Kylies has a total of 104 co-authors. Here are the top co-authors by number of shared publications:
- Victor G. Puelles
III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
5 shared publications - Malte Kuehl
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
4 shared publications Ilka Edenhofer
III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
3 shared publications- Maria Schwerk
III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
3 shared publications - Milagros N. Wong
III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
3 shared publications - Fabian Haas
III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
2 shared publications
Latest Publications
- Open Access
- 15 June 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (6) , e0351181
Kidney dysfunction is associated with mortality, adverse CT-based muscle metrics, and functional decline in surgically treated liposarcomas of the extremities and trunk
Background: Liposarcomas (LS) of the extremities and trunk are aggressive soft-tissue sarcomas and surgical resection combined with multimodal therapy represents the cornerstone of curative treatment. Despite advances in surgical and medical management patients are still at risk of developing medical complications that negatively affect morbidity and mortality. Kidney dysfunction, sarcopenia and progressive loss of visceral adipose tissue have emerged as prognostically relevant and potentially treatable complications in surgical oncology. However, despite their growing relevance, little is known about their frequency and impact on survival and morbidity in the context of LS. Methods: We conducted a retrospective study of 47 adult patients with localized LS of the extremities and trunk who underwent curative-intent surgery. Kidney function, CT morphometry of muscle (skeletal muscle index, SMI) and visceral adipose tissue (VAT) as well as clinical assessments including ECOG score were recorded at diagnosis (t1) and after a median follow-up (t2) of 11 months. Kidney dysfunction, defined as a decrease in eGFR of ≥ 25% between time points, was analyzed in relation to survival, sequentially assessed CT-morphometry of muscle and adipose tissue as well as functional status assessed by ECOG scores. Results: All patients underwent curative-intent surgical treatment with or without additional multimodal treatment (surgery only: 51.1%, additional radiation: 31.9%, additional chemotherapy: 38.3%). Kidney dysfunction was frequent in our cohort (53.2% of all patients) and significantly associated reduced overall survival in Kaplan–Meier, uni- and multivariate Cox proportional hazards regression models (multivariate hazard ratio: 6.7; p = 0.03). In addition, patients with kidney dysfunction experienced a significantly accelerated loss of SMI (p < 0.001) and VAT (p < 0.001) as well as accelerated functional deterioration measured by worsening ECOG scores between t1 and t2 compared to a stable ECOG score in patients without kidney dysfunction (odds ratio of ECOG increase of: 8.0; p = 0.0027). Conclusions: To our knowledge, this is among the first studies to investigate kidney dysfunction and its consequences in adult LS patients. In our cohort of surgically treated adult patients with LS of the extremities and trunk, kidney dysfunction was a frequent and clinically impactful complication. It was significantly associated with decreased overall survival, loss of muscle and adipose tissue in sequential CT morphometry assessments and progressive functional decline. Off note, CT-morphometry enabled objective, high-resolution tracking of body composition decline and may serve as a promising additional tool for risk stratification. Nonetheless, given the limited cohort size and retrospective single-center design, the generalizability of our findings is limited and the results should therefore be interpreted with caution. Despite these limitations, our findings call for future prospective studies and an awareness for heightened renal surveillance and integrated body composition assessments in the multimodal management of sarcoma patients.
- 15 June 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (6) , e0351181
Open AccessKidney dysfunction is associated with mortality, adverse CT-based muscle metrics, and functional decline in surgically treated liposarcomas of the extremities and trunk
Background: Liposarcomas (LS) of the extremities and trunk are aggressive soft-tissue sarcomas and surgical resection combined with multimodal therapy represents the cornerstone of curative treatment. Despite advances in surgical and medical management patients are still at risk of developing medical complications that negatively affect morbidity and mortality. Kidney dysfunction, sarcopenia and progressive loss of visceral adipose tissue have emerged as prognostically relevant and potentially treatable complications in surgical oncology. However, despite their growing relevance, little is known about their frequency and impact on survival and morbidity in the context of LS. Methods: We conducted a retrospective study of 47 adult patients with localized LS of the extremities and trunk who underwent curative-intent surgery. Kidney function, CT morphometry of muscle (skeletal muscle index, SMI) and visceral adipose tissue (VAT) as well as clinical assessments including ECOG score were recorded at diagnosis (t1) and after a median follow-up (t2) of 11 months. Kidney dysfunction, defined as a decrease in eGFR of ≥ 25% between time points, was analyzed in relation to survival, sequentially assessed CT-morphometry of muscle and adipose tissue as well as functional status assessed by ECOG scores. Results: All patients underwent curative-intent surgical treatment with or without additional multimodal treatment (surgery only: 51.1%, additional radiation: 31.9%, additional chemotherapy: 38.3%). Kidney dysfunction was frequent in our cohort (53.2% of all patients) and significantly associated reduced overall survival in Kaplan–Meier, uni- and multivariate Cox proportional hazards regression models (multivariate hazard ratio: 6.7; p = 0.03). In addition, patients with kidney dysfunction experienced a significantly accelerated loss of SMI (p < 0.001) and VAT (p < 0.001) as well as accelerated functional deterioration measured by worsening ECOG scores between t1 and t2 compared to a stable ECOG score in patients without kidney dysfunction (odds ratio of ECOG increase of: 8.0; p = 0.0027). Conclusions: To our knowledge, this is among the first studies to investigate kidney dysfunction and its consequences in adult LS patients. In our cohort of surgically treated adult patients with LS of the extremities and trunk, kidney dysfunction was a frequent and clinically impactful complication. It was significantly associated with decreased overall survival, loss of muscle and adipose tissue in sequential CT morphometry assessments and progressive functional decline. Off note, CT-morphometry enabled objective, high-resolution tracking of body composition decline and may serve as a promising additional tool for risk stratification. Nonetheless, given the limited cohort size and retrospective single-center design, the generalizability of our findings is limited and the results should therefore be interpreted with caution. Despite these limitations, our findings call for future prospective studies and an awareness for heightened renal surveillance and integrated body composition assessments in the multimodal management of sarcoma patients.
- Open Access
- 21 May 2026
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 12 (6) , e1956
Sequential Computed Tomography Morphometry–derived Muscle Loss Is Associated With Kidney Dysfunction and Mortality in Kidney Transplant Recipients Undergoing Serial Clinically Indicated Computed Tomography Imaging
Background.: Kidney transplantation is the optimal treatment for end-stage kidney disease, yet long-term outcomes remain heterogeneous, underscoring the need for improved clinical risk stratification. Sarcopenia assessed by computed tomography (CT)–based morphometry has emerged as a promising biomarker across multiple conditions, including solid organ transplantation. Importantly, muscle metrics can be derived from CT scans obtained for clinical indications, enabling opportunistic screening without additional imaging burden. However, longitudinal muscle trajectories after kidney transplantation derived from indication-driven CT imaging and their associations with graft dysfunction and survival remain poorly characterized. Methods.: In this retrospective single-center study, CT morphometry at the L3 level was analyzed in kidney transplant recipients who underwent 2 clinically indicated abdominal CT scans. Skeletal Muscle Index, Paraspinal Muscle Index, Psoas Muscle Index, and visceral adipose tissue were quantified. Longitudinal changes between both time points were related to kidney allograft dysfunction, defined as major adverse kidney events, and overall survival. Survival analyses were performed using Kaplan-Meier estimates and Cox proportional hazards models. Results.: Seventy-three kidney transplant recipients were included. Patients with allograft dysfunction demonstrated markedly accelerated muscle loss compared with those maintaining stable graft function. Muscle decline was primarily driven by progression to end-stage kidney disease, whereas isolated ≥25% estimated glomerular filtration rate decline without graft failure was not associated with significant sarcopenia progression. Adverse CT morphometry was independently associated with reduced survival in Kaplan-Meier and multivariable Cox regression analyses adjusted for age, sex, and major adverse kidney events. Conclusions.: Among kidney transplant recipients undergoing indication-driven imaging, posttransplant skeletal muscle loss is closely linked to allograft dysfunction and independently associated with mortality. Opportunistic CT-based morphometry may therefore represent a valuable tool for risk stratification in vulnerable transplant populations. Prospective studies are warranted to validate these findings and assess interventional implications.
- 21 May 2026
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 12 (6) , e1956
Open AccessSequential Computed Tomography Morphometry–derived Muscle Loss Is Associated With Kidney Dysfunction and Mortality in Kidney Transplant Recipients Undergoing Serial Clinically Indicated Computed Tomography Imaging
Background.: Kidney transplantation is the optimal treatment for end-stage kidney disease, yet long-term outcomes remain heterogeneous, underscoring the need for improved clinical risk stratification. Sarcopenia assessed by computed tomography (CT)–based morphometry has emerged as a promising biomarker across multiple conditions, including solid organ transplantation. Importantly, muscle metrics can be derived from CT scans obtained for clinical indications, enabling opportunistic screening without additional imaging burden. However, longitudinal muscle trajectories after kidney transplantation derived from indication-driven CT imaging and their associations with graft dysfunction and survival remain poorly characterized. Methods.: In this retrospective single-center study, CT morphometry at the L3 level was analyzed in kidney transplant recipients who underwent 2 clinically indicated abdominal CT scans. Skeletal Muscle Index, Paraspinal Muscle Index, Psoas Muscle Index, and visceral adipose tissue were quantified. Longitudinal changes between both time points were related to kidney allograft dysfunction, defined as major adverse kidney events, and overall survival. Survival analyses were performed using Kaplan-Meier estimates and Cox proportional hazards models. Results.: Seventy-three kidney transplant recipients were included. Patients with allograft dysfunction demonstrated markedly accelerated muscle loss compared with those maintaining stable graft function. Muscle decline was primarily driven by progression to end-stage kidney disease, whereas isolated ≥25% estimated glomerular filtration rate decline without graft failure was not associated with significant sarcopenia progression. Adverse CT morphometry was independently associated with reduced survival in Kaplan-Meier and multivariable Cox regression analyses adjusted for age, sex, and major adverse kidney events. Conclusions.: Among kidney transplant recipients undergoing indication-driven imaging, posttransplant skeletal muscle loss is closely linked to allograft dysfunction and independently associated with mortality. Opportunistic CT-based morphometry may therefore represent a valuable tool for risk stratification in vulnerable transplant populations. Prospective studies are warranted to validate these findings and assess interventional implications.
- 2 July 2025
- Published by Springer Nature in Nature Protocols
- Vol. 21 (1) , 107-139
Expansion and fluctuations-enhanced microscopy for nanoscale molecular profiling of cells and tissues
Advances in super-resolution microscopy enable the molecular profiling of cells and tissues at the nanoscale level, surpassing the diffraction limit of conventional light microscopy. However, super-resolution techniques typically require access to expensive specialized equipment and extensive training, limiting their broad applicability. Here we provide a detailed protocol for combining expansion microscopy with enhanced super-resolution radial fluctuations analysis to achieve nanoscale resolution using conventional microscopes. Expansion microscopy physically enlarges the sample, while enhanced super-resolution radial fluctuations computationally enhances the image resolution by analyzing fluorescence fluctuations over time. By combining both, we achieve images with a resolution of 25 nm in combination with diffraction-limited microscopes. Our step-by-step instructions include the expansion of cells and tissue samples, the optimization of multispectral microscopy parameters and the implementation of quality control metrics to minimize artifacts. We further cover the use of quantitative tools such as NanoJ-SQUIRREL, which enable the assessment of resolution improvements and image fidelity. We discuss key considerations for each stage, including sample preparation, image acquisition, computational processing and downstream analysis. Potential pitfalls and troubleshooting strategies are also addressed. This protocol can be used for imaging a variety of sample types with multiple fluorescent labels. With nanoscale spatial resolution and molecular specificity, expansion-enhanced super-resolution radial fluctuations microscopy provides a flexible, accessible approach for investigating cellular ultrastructure, protein localization and interaction networks, suitable for applications in cell biology, histopathology and biomedical research. The procedure requires 3–4 d to complete, involving ~7–9 h of total bench, imaging and processing time and only requires basic expertise in tissue handling, molecular and cell biology, and microscopy.
- 2 July 2025
- Published by Springer Nature in Nature Protocols
- Vol. 21 (1) , 107-139
Expansion and fluctuations-enhanced microscopy for nanoscale molecular profiling of cells and tissues
Advances in super-resolution microscopy enable the molecular profiling of cells and tissues at the nanoscale level, surpassing the diffraction limit of conventional light microscopy. However, super-resolution techniques typically require access to expensive specialized equipment and extensive training, limiting their broad applicability. Here we provide a detailed protocol for combining expansion microscopy with enhanced super-resolution radial fluctuations analysis to achieve nanoscale resolution using conventional microscopes. Expansion microscopy physically enlarges the sample, while enhanced super-resolution radial fluctuations computationally enhances the image resolution by analyzing fluorescence fluctuations over time. By combining both, we achieve images with a resolution of 25 nm in combination with diffraction-limited microscopes. Our step-by-step instructions include the expansion of cells and tissue samples, the optimization of multispectral microscopy parameters and the implementation of quality control metrics to minimize artifacts. We further cover the use of quantitative tools such as NanoJ-SQUIRREL, which enable the assessment of resolution improvements and image fidelity. We discuss key considerations for each stage, including sample preparation, image acquisition, computational processing and downstream analysis. Potential pitfalls and troubleshooting strategies are also addressed. This protocol can be used for imaging a variety of sample types with multiple fluorescent labels. With nanoscale spatial resolution and molecular specificity, expansion-enhanced super-resolution radial fluctuations microscopy provides a flexible, accessible approach for investigating cellular ultrastructure, protein localization and interaction networks, suitable for applications in cell biology, histopathology and biomedical research. The procedure requires 3–4 d to complete, involving ~7–9 h of total bench, imaging and processing time and only requires basic expertise in tissue handling, molecular and cell biology, and microscopy.
- 1 July 2025
- Published by Wolters Kluwer Health in Hypertension
- Vol. 82 (7) , 1167-1174
Incretin-Based Therapies: A Paradigm Shift in Blood Pressure Management?
In the management of hypertension, only limited advances have been made over the past decades. Recent studies highlight the potential of next-generation incretin-based therapeutics, such as GLP-1 RAs (glucagon-like peptide-1 receptor agonists) like semaglutide and dual GLP-1/GIP (glucose-dependent insulinotropic polypeptide) receptor agonists like tirzepatide. These drugs not only promote weight loss but also substantially lower blood pressure (BP) and reduce cardiovascular end points. The extent to which incretin-based therapies improve disease outcomes via weight loss versus so-called direct tissue effects is the subject of great interest, not only for BP but also for other clinical outcomes. Although, incretin-based therapeutics were initially not designed to treat hypertension, clinical studies demonstrate an impressive reduction in BP in patients treated with these agents, with an even more pronounced effect in patients with obesity and hypertension. The current hypertension guidelines must address the robust evidence supporting the use of incretin-based therapeutics in patients with hypertension. A caveat is that no trial to date has used BP reduction as the primary end point when investigating the interaction between GLP-1 or GLP-1/GIP receptor agonists and antihypertensive medications. However, in patients with type 2 diabetes or a body mass index >27 kg/m 2 , these drugs are widely used and lower BP. Taken together, incretin-based therapeutics represent a promising therapeutic tool to improve both BP and cardiovascular outcomes and help evolve the landscape of hypertension treatment.
- 1 July 2025
- Published by Wolters Kluwer Health in Hypertension
- Vol. 82 (7) , 1167-1174
Incretin-Based Therapies: A Paradigm Shift in Blood Pressure Management?
In the management of hypertension, only limited advances have been made over the past decades. Recent studies highlight the potential of next-generation incretin-based therapeutics, such as GLP-1 RAs (glucagon-like peptide-1 receptor agonists) like semaglutide and dual GLP-1/GIP (glucose-dependent insulinotropic polypeptide) receptor agonists like tirzepatide. These drugs not only promote weight loss but also substantially lower blood pressure (BP) and reduce cardiovascular end points. The extent to which incretin-based therapies improve disease outcomes via weight loss versus so-called direct tissue effects is the subject of great interest, not only for BP but also for other clinical outcomes. Although, incretin-based therapeutics were initially not designed to treat hypertension, clinical studies demonstrate an impressive reduction in BP in patients treated with these agents, with an even more pronounced effect in patients with obesity and hypertension. The current hypertension guidelines must address the robust evidence supporting the use of incretin-based therapeutics in patients with hypertension. A caveat is that no trial to date has used BP reduction as the primary end point when investigating the interaction between GLP-1 or GLP-1/GIP receptor agonists and antihypertensive medications. However, in patients with type 2 diabetes or a body mass index >27 kg/m 2 , these drugs are widely used and lower BP. Taken together, incretin-based therapeutics represent a promising therapeutic tool to improve both BP and cardiovascular outcomes and help evolve the landscape of hypertension treatment.
- Open Access
- 25 April 2025
- Published by AIP Publishing in Applied Physics Reviews
- Vol. 12 (2)
Nanoscale imaging of biological systems via expansion and super-resolution microscopy
Super-resolution microscopy (SRM) has revolutionized life sciences by overcoming the diffraction limit, enabling the visualization of biological structures at the nanoscale. Expansion Microscopy (ExM) has emerged as a powerful and accessible technique that enhances resolution by physically enlarging the specimen. Importantly, the principles of ExM provide a unique foundation for combinations with SRM methods, pushing the boundaries of achievable resolution. This review explores the fundamental principles of ExM and examines its successful integration with various SRM techniques, including fluorescence fluctuation-based SRM, structured illumination microscopy, stimulated emission depletion microscopy, and single-molecule localization microscopy. We discuss the applications, strengths, limitations, and resolutions achieved by these combined approaches, providing a comprehensive guide for researchers to select the most suitable method for their specific scientific needs. Key considerations when combining ExM with SRM include the impact on fluorophores, the requirement for specialized buffers, and the challenges posed by the sensitivity of expanded hydrogels to temperature and hydration. Strategies to address these challenges, such as optimized labeling techniques and gel re-embedding, are discussed in detail. This review aims to assist researchers in navigating the rapidly evolving landscape of ExM and SRM, facilitating the development of tailored imaging pipelines to advance our understanding of biological systems at the nanoscale.
- 25 April 2025
- Published by AIP Publishing in Applied Physics Reviews
- Vol. 12 (2)
Open AccessNanoscale imaging of biological systems via expansion and super-resolution microscopy
Super-resolution microscopy (SRM) has revolutionized life sciences by overcoming the diffraction limit, enabling the visualization of biological structures at the nanoscale. Expansion Microscopy (ExM) has emerged as a powerful and accessible technique that enhances resolution by physically enlarging the specimen. Importantly, the principles of ExM provide a unique foundation for combinations with SRM methods, pushing the boundaries of achievable resolution. This review explores the fundamental principles of ExM and examines its successful integration with various SRM techniques, including fluorescence fluctuation-based SRM, structured illumination microscopy, stimulated emission depletion microscopy, and single-molecule localization microscopy. We discuss the applications, strengths, limitations, and resolutions achieved by these combined approaches, providing a comprehensive guide for researchers to select the most suitable method for their specific scientific needs. Key considerations when combining ExM with SRM include the impact on fluorophores, the requirement for specialized buffers, and the challenges posed by the sensitivity of expanded hydrogels to temperature and hydration. Strategies to address these challenges, such as optimized labeling techniques and gel re-embedding, are discussed in detail. This review aims to assist researchers in navigating the rapidly evolving landscape of ExM and SRM, facilitating the development of tailored imaging pipelines to advance our understanding of biological systems at the nanoscale.
- 1 April 2025
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 328 (4) , H814-H829
Aortic aneurysm and dissection: complement and precision medicine in aortic disease
Aortic disease encompasses life-threatening conditions such as aortic aneurysm and dissection, which are associated with high prevalence, morbidity, and mortality. The complement system, a key component of innate immunity, not only defends against pathogens but also maintains tissue homeostasis. Recent discoveries have expanded its role beyond immunity, linking complement dysregulation to numerous diseases and positioning it as a target for pharmacotherapy. Complement-based treatments for precision medicine are emerging, with several pharmaceuticals either already approved or under investigation. In aortic disease, complement activation and dysregulation have unveiled novel mechanisms and clinical implications. Human and experimental studies suggest that all three complement pathways contribute to disease pathophysiology. The complement system induces direct cellular damage via the membrane attack complex, as well as matrix-metalloproteinase (MMP)-associated tissue damage by promoting MMP-2 and MMP-9 expression. The anaphylatoxins C3a and C5a exacerbate disease by recruiting immune cells and triggering proinflammatory responses. Examples include neutrophil extracellular trap formation and cytokine release by polymorphonuclear neutrophils. These findings highlight the complement system as a promising novel diagnostic and therapeutic target in aortic disease with potential for individualized treatment. However, gaps remain, emphasizing the need for standardized multisite preclinical studies to improve reproducibility and translation. Biomarker studies must also be validated across diverse patient cohorts for clinical applicability. This review examines current knowledge regarding complement in aortic disease, aiming to evaluate its potential for innovative diagnostic and personalized treatment strategies.
- 1 April 2025
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 328 (4) , H814-H829
Aortic aneurysm and dissection: complement and precision medicine in aortic disease
Aortic disease encompasses life-threatening conditions such as aortic aneurysm and dissection, which are associated with high prevalence, morbidity, and mortality. The complement system, a key component of innate immunity, not only defends against pathogens but also maintains tissue homeostasis. Recent discoveries have expanded its role beyond immunity, linking complement dysregulation to numerous diseases and positioning it as a target for pharmacotherapy. Complement-based treatments for precision medicine are emerging, with several pharmaceuticals either already approved or under investigation. In aortic disease, complement activation and dysregulation have unveiled novel mechanisms and clinical implications. Human and experimental studies suggest that all three complement pathways contribute to disease pathophysiology. The complement system induces direct cellular damage via the membrane attack complex, as well as matrix-metalloproteinase (MMP)-associated tissue damage by promoting MMP-2 and MMP-9 expression. The anaphylatoxins C3a and C5a exacerbate disease by recruiting immune cells and triggering proinflammatory responses. Examples include neutrophil extracellular trap formation and cytokine release by polymorphonuclear neutrophils. These findings highlight the complement system as a promising novel diagnostic and therapeutic target in aortic disease with potential for individualized treatment. However, gaps remain, emphasizing the need for standardized multisite preclinical studies to improve reproducibility and translation. Biomarker studies must also be validated across diverse patient cohorts for clinical applicability. This review examines current knowledge regarding complement in aortic disease, aiming to evaluate its potential for innovative diagnostic and personalized treatment strategies.
- 1 November 2024
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 327 (5) , F822-F844
Optimized protocol for the multiomics processing of cryopreserved human kidney tissue
In this study, we addressed challenges in integrating clinically obtained kidney biopsies into everyday clinical routines. Using porcine kidneys, we evaluated preservation media (RNAlater and CellCover) versus snap freezing for multi-omics processing. Our analyses highlighted RNAlater’s suitability for single-nucleus RNA sequencing, proteome analysis and histopathological evaluation. Only metabolomics are currently restricted to snap-frozen biopsies. Our research established a cryopreservation protocol that facilitates tissue biobanking for advancing precision medicine in nephrology.
- 1 November 2024
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 327 (5) , F822-F844
Optimized protocol for the multiomics processing of cryopreserved human kidney tissue
In this study, we addressed challenges in integrating clinically obtained kidney biopsies into everyday clinical routines. Using porcine kidneys, we evaluated preservation media (RNAlater and CellCover) versus snap freezing for multi-omics processing. Our analyses highlighted RNAlater’s suitability for single-nucleus RNA sequencing, proteome analysis and histopathological evaluation. Only metabolomics are currently restricted to snap-frozen biopsies. Our research established a cryopreservation protocol that facilitates tissue biobanking for advancing precision medicine in nephrology.
- Top Cited Papers
- 5 April 2024
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 384 (6691) , eabo7027
Apoptotic cell identity induces distinct functional responses to IL-4 in efferocytic macrophages
Macrophages are functionally heterogeneous cells essential for apoptotic cell clearance. Apoptotic cells are defined by homogeneous characteristics, ignoring their original cell lineage identity. We found that in an interleukin-4 (IL-4)–enriched environment, the sensing of apoptotic neutrophils by macrophages triggered their tissue remodeling signature. Engulfment of apoptotic hepatocytes promoted a tolerogenic phenotype, whereas phagocytosis of T cells had little effect on IL-4–induced gene expression. In a mouse model of parasite-induced pathology, the transfer of macrophages conditioned with IL-4 and apoptotic neutrophils promoted parasitic egg clearance. Knockout of phagocytic receptors required for the uptake of apoptotic neutrophils and partially T cells, but not hepatocytes, exacerbated helminth infection. These findings suggest that the identity of apoptotic cells may contribute to the development of distinct IL-4–driven immune programs in macrophages.
- 5 April 2024
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 384 (6691) , eabo7027
Top Cited PapersApoptotic cell identity induces distinct functional responses to IL-4 in efferocytic macrophages
Macrophages are functionally heterogeneous cells essential for apoptotic cell clearance. Apoptotic cells are defined by homogeneous characteristics, ignoring their original cell lineage identity. We found that in an interleukin-4 (IL-4)–enriched environment, the sensing of apoptotic neutrophils by macrophages triggered their tissue remodeling signature. Engulfment of apoptotic hepatocytes promoted a tolerogenic phenotype, whereas phagocytosis of T cells had little effect on IL-4–induced gene expression. In a mouse model of parasite-induced pathology, the transfer of macrophages conditioned with IL-4 and apoptotic neutrophils promoted parasitic egg clearance. Knockout of phagocytic receptors required for the uptake of apoptotic neutrophils and partially T cells, but not hepatocytes, exacerbated helminth infection. These findings suggest that the identity of apoptotic cells may contribute to the development of distinct IL-4–driven immune programs in macrophages.
- Open Access
- 10 April 2023
- Published by Springer Nature in Nature Nanotechnology
- Vol. 18 (4) , 336-342
Expansion-enhanced super-resolution radial fluctuations enable nanoscale molecular profiling of pathology specimens
Expansion microscopy physically enlarges biological specimens to achieve nanoscale resolution using diffraction-limited microscopy systems1. However, optimal performance is usually reached using laser-based systems (for example, confocal microscopy), restricting its broad applicability in clinical pathology, as most centres have access only to light-emitting diode (LED)-based widefield systems. As a possible alternative, a computational method for image resolution enhancement, namely, super-resolution radial fluctuations (SRRF)2,3, has recently been developed. However, this method has not been explored in pathology specimens to date, because on its own, it does not achieve sufficient resolution for routine clinical use. Here, we report expansion-enhanced super-resolution radial fluctuations (ExSRRF), a simple, robust, scalable and accessible workflow that provides a resolution of up to 25 nm using LED-based widefield microscopy. ExSRRF enables molecular profiling of subcellular structures from archival formalin-fixed paraffin-embedded tissues in complex clinical and experimental specimens, including ischaemic, degenerative, neoplastic, genetic and immune-mediated disorders. Furthermore, as examples of its potential application to experimental and clinical pathology, we show that ExSRRF can be used to identify and quantify classical features of endoplasmic reticulum stress in the murine ischaemic kidney and diagnostic ultrastructural features in human kidney biopsies.
- 10 April 2023
- Published by Springer Nature in Nature Nanotechnology
- Vol. 18 (4) , 336-342
Open AccessExpansion-enhanced super-resolution radial fluctuations enable nanoscale molecular profiling of pathology specimens
Expansion microscopy physically enlarges biological specimens to achieve nanoscale resolution using diffraction-limited microscopy systems1. However, optimal performance is usually reached using laser-based systems (for example, confocal microscopy), restricting its broad applicability in clinical pathology, as most centres have access only to light-emitting diode (LED)-based widefield systems. As a possible alternative, a computational method for image resolution enhancement, namely, super-resolution radial fluctuations (SRRF)2,3, has recently been developed. However, this method has not been explored in pathology specimens to date, because on its own, it does not achieve sufficient resolution for routine clinical use. Here, we report expansion-enhanced super-resolution radial fluctuations (ExSRRF), a simple, robust, scalable and accessible workflow that provides a resolution of up to 25 nm using LED-based widefield microscopy. ExSRRF enables molecular profiling of subcellular structures from archival formalin-fixed paraffin-embedded tissues in complex clinical and experimental specimens, including ischaemic, degenerative, neoplastic, genetic and immune-mediated disorders. Furthermore, as examples of its potential application to experimental and clinical pathology, we show that ExSRRF can be used to identify and quantify classical features of endoplasmic reticulum stress in the murine ischaemic kidney and diagnostic ultrastructural features in human kidney biopsies.